{"id":1421,"date":"2020-02-10T10:23:31","date_gmt":"2020-02-10T10:23:31","guid":{"rendered":"https:\/\/www.ipsen.com\/spain\/?p=1421"},"modified":"2024-12-16T13:13:30","modified_gmt":"2024-12-16T11:13:30","slug":"carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/","title":{"rendered":"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal"},"content":{"rendered":"\n<p><strong>Barcelona, 10 de febrero de 2020.<\/strong>&#8211; Ipsen, compa\u00f1\u00eda biofarmac\u00e9utica global centrada en innovaci\u00f3n y atenci\u00f3n especializada, ha nombrado a Carlos Reboll nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen Iberia.<\/p>\n\n\n\n<p>Carlos Reboll cuenta con una dilatada experiencia en la industria farmac\u00e9utica donde ha desempe\u00f1ado diferentes cargos de responsabilidad durante los \u00faltimos 15 a\u00f1os. Desde su nuevo puesto en Ipsen reportar\u00e1 directamente a Aurora Berra, directora general de la compa\u00f1\u00eda para Espa\u00f1a y Portugal, y formar\u00e1 parte del comit\u00e9 de direcci\u00f3n.<\/p>\n\n\n\n<p>\u201cOncolog\u00eda es una de las \u00e1reas terap\u00e9uticas estrat\u00e9gicas para Ipsen en Espa\u00f1a y Portugal. Ser el responsable para ambos mercados es un reto que afronto con gran ilusi\u00f3n y responsabilidad. Me enorgullece contribuir a consolidar esta unidad de negocio y a mejorar la vida de los pacientes con c\u00e1ncer\u201d, ha afirmado Carlos Reboll. \u201cAfrontamos el a\u00f1o 2020 con el convencimiento de seguir afianzando la posici\u00f3n de liderazgo de la compa\u00f1\u00eda en este campo. Estoy segura de que la experiencia de Carlos Reboll nos aportar\u00e1 un importante valor a\u00f1adido para alcanzar este objetivo\u201d, ha explicado Aurora Berra.<\/p>\n\n\n\n<p>Carlos Reboll es licenciado en Ciencias F\u00edsicas y tiene un MBA por el IESE Business School. Reboll inici\u00f3 su carrera en la industria farmac\u00e9utica como Product Manager y Senior Product Manager en Lilly y Bristol-Myers Squibb, respectivamente. En Novo Nordisk ocup\u00f3 los cargos de Marketing Manager y European Brand Lead. Posteriormente, desempe\u00f1\u00f3 las labores de Head of Marketing of Hematology en Baxalta y de Head of Business Planning &amp; Operations en Shire. Ahora se incorpora a Ipsen procedente de Takeda, donde ha sido Business Unit Director Neuroscience.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br>Acerca de Ipsen<\/h4>\n\n\n\n<p>Ipsen es una compa\u00f1\u00eda biofarmac\u00e9utica global centrada en la innovaci\u00f3n y atenci\u00f3n especializada. La compa\u00f1\u00eda desarrolla y comercializa medicamentos innovadores en 3 \u00e1reas terap\u00e9uticas clave: oncolog\u00eda, neurociencias y enfermedades raras. Su compromiso con la oncolog\u00eda se traduce en una cartera creciente de terapias clave para c\u00e1ncer de pr\u00f3stata, tumores neuroendocrinos, carcinomas de c\u00e9lulas renales, hepatocarcinoma y c\u00e1ncer de p\u00e1ncreas. Ipsen tambi\u00e9n est\u00e1 presente en atenci\u00f3n primaria y autocuidado de la salud.<\/p>\n\n\n\n<p>Con un volumen de negocio de 2.200 millones de euros en 2018, Ipsen comercializa m\u00e1s de 20 medicamentos en m\u00e1s de 115 pa\u00edses, y cuenta con presencia comercial directa en m\u00e1s de 30 pa\u00edses. La I+D de Ipsen se centra en sus plataformas tecnol\u00f3gicas diferenciadas e innovadoras, ubicadas en los principales centros biotecnol\u00f3gicos y ciudades de referencia en ciencias de la vida: Par\u00eds-Saclay (Francia), Oxford (Reino Unido) y Cambridge (Estados Unidos). El grupo cuenta con unos 5.700 empleados en todo el mundo.<\/p>\n\n\n\n<p>Ipsen cotiza en la bolsa de Par\u00eds (Euronext: IPN), y, en Estados Unidos, participa en el American Depositary Receipt program patrocinado de nivel 1.<\/p>\n\n\n\n<p>Ipsen Pharma Espa\u00f1a se encuentra ubicada en Hospitalet de Llobregat (Barcelona). En Espa\u00f1a, la compa\u00f1\u00eda dispone de un s\u00f3lido porfolio en oncolog\u00eda (ri\u00f1\u00f3n, pr\u00f3stata, h\u00edgado y tumores neuroendocrinos), enfermedades raras (acromegalia y trastornos del crecimiento) y neurociencias (trastornos del movimiento). Para m\u00e1s informaci\u00f3n, visita los sitios web: <a href=\"https:\/\/www.ipsen.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>www.ipsen.com<\/strong><\/a> y <a href=\"https:\/\/www.ipsen.com\/spain\/\"><strong>www.ipsen.com\/spain<\/strong><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong>Para m\u00e1s informaci\u00f3n:<\/strong><\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Ipsen<\/strong><br><br>Loreto Gonz\u00e1lez Goizueta<br>Tel\u00e9fono: 93 685 81 00<br>Email: <a href=\"mailto:loreto.gonzalez@ipsen.com\" target=\"_blank\" rel=\"noreferrer noopener\">loreto.gonzalez@ipsen.com<\/a><\/td><td><strong>Duomo Comunicaci\u00f3n<\/strong><br><br><strong>Borja G\u00f3mez<\/strong><br>Tel\u00e9fono: 91 311 92 89 \/90<br><a href=\"mailto:borja_gomez@duomocomunicacion.com\" target=\"_blank\" rel=\"noreferrer noopener\">borja_gomez@duomocomunicacion.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","categories":[39],"tags":[],"class_list":["post-1421","press_release","type-press_release","status-publish","hentry","category-notas-de-prensa","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:site_name\" content=\"Spain\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T11:13:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/\",\"url\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/\",\"name\":\"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\"},\"datePublished\":\"2020-02-10T10:23:31+00:00\",\"dateModified\":\"2024-12-16T11:13:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/spain\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"name\":\"Spain\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\",\"name\":\"Spain\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"caption\":\"Spain\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/","og_locale":"es_ES","og_type":"article","og_title":"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain","og_url":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/","og_site_name":"Spain","article_modified_time":"2024-12-16T11:13:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/","url":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/","name":"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal - Spain","isPartOf":{"@id":"https:\/\/www.ipsen.com\/spain\/#website"},"datePublished":"2020-02-10T10:23:31+00:00","dateModified":"2024-12-16T11:13:30+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/carlos-reboll-nuevo-director-de-la-unidad-de-negocio-de-oncologia-de-ipsen-para-espana-y-portugal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/spain\/"},{"@type":"ListItem","position":2,"name":"Carlos Reboll, nuevo director de la Unidad de Negocio de Oncolog\u00eda de Ipsen para Espa\u00f1a y Portugal"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/spain\/#website","url":"https:\/\/www.ipsen.com\/spain\/","name":"Spain","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/spain\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/spain\/#organization","name":"Spain","url":"https:\/\/www.ipsen.com\/spain\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","caption":"Spain"},"image":{"@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/users\/11"}],"version-history":[{"count":3,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1421\/revisions"}],"predecessor-version":[{"id":3048,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1421\/revisions\/3048"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/media?parent=1421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/categories?post=1421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/tags?post=1421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}